Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-05-13

Clinical Trial Update: G-Pen Compared to Glucagen Hypokit for Severe Hypoglycemia Rescue in Adults With Type 1 Diabetes [Phase 3]

View source ↗

Summary

Phase 3 trial update comparing G-Pen to Glucagon Hypokit for severe hypoglycemia rescue in adults with type 1 diabetes; study completed with results posted in 2…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • G-Pen (glucagon)
  • Glucagon Hypokit

Snippet

Sponsor: Xeris Pharmaceuticals | Conditions: Insulin Hypoglycemia, Type 1 Diabetes Mellitus | Phase 3 | Status: COMPLETED | Results posted: 2020-05-13